---
title: "Global adoption of openEHR Clinical Data Repositories: vendor and community survey findings"
id: "medrxiv-2-global-adoption-of-openehr-clinical-data-repositories-a-vendor-and-community"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-global-adoption-of-openehr-clinical-data-repositories-a-vendor-and-community"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1?rss=1"
published_at: "2026-08-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Global adoption of openEHR Clinical Data Repositories: vendor and community survey findings
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-global-adoption-of-openehr-clinical-data-repositories-a-vendor-and-community
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1?rss=1)
- **Published At:** 2026-08-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The openEHR standard offers an open, vendor-neutral architecture for **Clinical Data Repositories** (CDRs); real-world deployment had not been systematically documented prior to this work. - The authors ran a dual-perspective survey: a vendor survey of openEHR CDR providers and a community survey of openEHR practitioners. - Eleven vendor organisations reported deployments spanning **22 countries** and more than **100 institutions and health regions**. - The community survey included 29 respondents across **17 countries**, providing context on regulatory environments, adoption drivers, and barriers. - Combined coverage includes **28 countries**, of which **26** were reported to have an openEHR CDR deployment. - Two distinct channels delivered national-scale presence: vendor-market convergence (extensive regional coverage without national mandate) and government-led national health record adoption built on openEHR. - Examples of broad regional coverage: 19 of 21 Swedish regions, 3 of 4 Norwegian health regions, and 16 of 21 Finnish wellbeing services counties. - Countries with national systems founded on openEHR include Ireland, Malta, Greece, Jamaica and Slovenia. - No country was identified where openEHR is explicitly named in binding national regulation, which the authors note creates structural fragility and an unrealised alignment opportunity with the European Health Data Space (EHDS). - Deployment purpose: **61%** of deployments serve primary care/use only; **12%** support both primary and secondary use. - The most consistent barrier across geographies and deployment levels is lack of **openEHR-specific knowledge**; adoption is practitioner- and innovation-driven rather than mandate-driven. - Survey instruments and aggregated country-level data are available from the corresponding author on reasonable request; individual vendor responses remain confidential per assurances of anonymity.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=o3cjI0M8YUxz95MzZn8Udj1LPzyatGsHL94BZXSNVT4-1788231034.72254-1.2.1.1-sZeEYbBkGH7UvvcP1JpGcce_AKMSS07ut99UxVfBB6i0uorzRmLve.Nx3aWFzCE.) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Global Adoption of openEHR Clinical Data Repositories: A Vendor and Community Survey [ View ORCID Profile](http://orcid.org/0000-0002-7718-6187)Severin Kohler, [ View ORCID Profile](http://orcid.org/0009-0000-9813-0249)Falk Meyer-Eschenbach, [ View ORCID Profile](http://orcid.org/0000-0002-5352-919X)Xabier Michelena, [ View ORCID Profile](http://orcid.org/0000-0002-5921-3073)Michael Marschollek, [ View ORCID Profile](http://orcid.org/0000-0002-0034-4036)Roland Eils doi: https://doi.org/10.64898/2026.08.27.26361529 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Severin Kohler 1 Digital Health Center, Berlin Institute of Health at Charite - Universitaetsmedizin Berlin, Berlin, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Severin%2BKohler%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kohler%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASeverin%2BKohler%2B) * [ORCID record for Severin Kohler](http://orcid.org/0000-0002-7718-6187 "Open in new tab") * For correspondence: severin.kohler@bih-charite.de Falk Meyer-Eschenbach 2 Institute of Medical Informatics, Charite - Universitaetsmedizin Berlin, Berlin, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Falk%2BMeyer-Eschenbach%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Meyer-Eschenbach%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFalk%2BMeyer-Eschenbach%2B) * [ORCID record for Falk Meyer-Eschenbach](http://orcid.org/0009-0000-9813-0249 "Open in new tab") Xabier Michelena 3 Servei Catala de la Salut, Digitalization for the Sustainability of the Healthcare System (DS3), Barcelona, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Xabier%2BMichelena%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Michelena%20X&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AXabier%2BMichelena%2B) * [ORCID record for Xabier Michelena](http://orcid.org/0000-0002-5352-919X "Open in new tab") Michael Marschollek 4 Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Hannover, Germany * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BMarschollek%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Marschollek%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BMarschollek%2B) * [ORCID record for Michael Marschollek](http://orcid.org/0000-0002-5921-3073 "Open in new tab") Roland Eils 1 Digital Health Center, Berlin Institute of Health at Charite - Universitaetsmedizin Berlin, Berlin, Germany; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Roland%2BEils%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Eils%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARoland%2BEils%2B) * [ORCID record for Roland Eils](http://orcid.org/0000-0002-0034-4036 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1289361/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1289361/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1289361/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1289361/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1289361/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract The openEHR standard provides an open, vendor-neutral architecture for clinical data repositories (CDRs), yet its real-world deployment has not been systematically documented. We conducted a dual-perspective survey combining a vendor survey of openEHR CDR providers with a community survey of openEHR practitioners. Eleven vendor organisations reported deployments across 22 countries and over 100 institutions and health regions. A complementary community survey (n=29, 17 countries) provided context on regulatory environments, adoption drivers, and barriers. Combined, the surveys cover 28 countries, 26 of them with a reported openEHR CDR deployment. Three findings emerge: openEHR has achieved national-scale presence through two distinct channels. Through vendor-market convergence, openEHR-based systems cover the majority of regional health authorities without a national mandate, including 19 of 21 Swedish regions, 3 of 4 Norwegian health regions, and 16 of 21 Finnish wellbeing services counties. Through national health record adoption, governments have built or procured national systems on openEHR as their technical foundation, including Ireland, Malta, Greece, Jamaica and Slovenia. Across Europe, this constitutes an openEHR-based interoperability infrastructure already in place across multiple EU member states. We identified no country in which openEHR is named in binding national regulation, creating structural fragility and an unrealised opportunity for alignment with the European Health Data Space (EHDS). Second, 61% of deployments serve primary use only, and 12% support both primary and secondary use. Third, lack of openEHR-specific knowledge is the most consistent adoption barrier across all geographies and deployment tiers. Adoption is driven by practitioner need and innovation, not by regulatory mandate. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The survey instruments and the aggregated country-level data supporting the conclusions of this article are available from the corresponding author on reasonable request. Individual vendor responses are not publicly available because respondents were assured of organisational anonymity. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.27.26361497v1 "Novel Entropy-Based Framework for Quantifying Dynamic Epistemic Uncertainty in Clinical Medicine")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.29.26361718v1 "Tumor-adjacent B cell infiltration stratifies recurrence risk in localized prostate cancer") Posted August 31, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/31/2026.08.27.26361529.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.27.26361529v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/31/2026.08.27.26361529.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Global Adoption of openEHR Clinical Data Repositories: A Vendor and Community Survey Severin Kohler, Falk Meyer-Eschenbach, Xabier Michelena, Michael Marschollek, Roland Eils medRxiv 2026.08.27.26361529; doi: https://doi.org/10.64898/2026.08.27.26361529 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361529v1%26text%3DGlobal%2520Adoption%2520of%2520openEHR%2520Clinical%2520Data%2520Repositories%253A%2520A%2520Vendor%2520and%2520Community%2520Survey "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361529v1%26t%3DGlobal%2520Adoption%2520of%2520openEHR%2520Clinical%2520Data%2520Repositories%253A%2520A%2520Vendor%2520and%2520Community%2520Survey "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361529v1%26title%3DGlobal%2520Adoption%2520of%2520openEHR%2520Clinical%2520Data%2520Repositories%253A%2520A%2520Vendor%2520and%2520Community%2520Survey%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.27.26361529v1%26title%3DGlobal%2520Adoption%2520of%2520openEHR%2520Clinical%2520Data%2520Repositories%253A%2520A%2520Vendor%2520and%2520Community%2520Survey "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.27.26361529) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.27.26361529v1&count=horizontal&via=&text=Global%20Adoption%20of%20openEHR%20Clinical%20Data%20Repositories%3A%20A%20Vendor%20and%20Community%20Survey&counturl=www.medrxiv.org/content/10.64898/2026.08.27.26361529v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (613) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (895) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (326) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4766) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (474) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (643) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1613) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15828) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1194) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6980) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1057) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4974) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1425) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1734) * [Hematology](https://www.medrxiv.org/collection/hematology) (579) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1333) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16241) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1160) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (663) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (151) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (720) * [Neurology](https://www.medrxiv.org/collection/neurology) (7188) * [Nursing](https://www.medrxiv.org/collection/nursing) (363) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1072) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1230) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1000) * [Oncology](https://www.medrxiv.org/collection/oncology) (3568) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1036) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (393) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (446) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (465) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1772) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (732) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (758) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5828) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9686) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2386) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1432) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1239) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (633) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (765) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (575) * [Surgery](https://www.medrxiv.org/collection/surgery) (766) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (302) * [Urology](https://www.medrxiv.org/collection/urology) (286) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP m
## Related Clinical Research

- [Adjusting unmet need for contraception by including husband’s virility in the Revised algorithm](https://medichelpline.com/clinical-feed/plos-one-2-incorporating-husband-s-influence-in-estimating-unmet-need-for-contraception.md)
- [Service Provider Competence, Motivation, and Resources as Determinants of Quality Healthcare at Ma](https://medichelpline.com/clinical-feed/medrxiv-6-service-provider-competence-motivation-and-resource-availability-as.md)
- [CMS Medicaid rule on pediatric transgender care could set precedent to restrict drug coverage](https://medichelpline.com/clinical-feed/stat-news-1-stat-medicaid-transgender-care-rule-sets-precedent-that-could-restrict-coverage.md)
- [FDA Signals Upcoming Regulatory Guidance for Generative AI in Medical Devices](https://medichelpline.com/clinical-feed/stat-news-2-stat-fda-digital-health-leader-promises-generative-ai-regulatory-guidance-is.md)
- [TabMedQA: Generating Guideline-Grounded EHR Question–Answer Datasets for Early Clinical Decisions](https://medichelpline.com/clinical-feed/medrxiv-14-tabmedqa-from-structured-data-to-question-answer-datasets-in-early-clinical.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.